首页> 外文期刊>Polymer engineering and science >Dual Drug Spatiotemporal Release From Functional Gradient Scaffolds Prepared Using 3D Bioprinting and Electrospinning
【24h】

Dual Drug Spatiotemporal Release From Functional Gradient Scaffolds Prepared Using 3D Bioprinting and Electrospinning

机译:从使用3D生物打印和静电纺丝制备的功能梯度支架中的双重药物时空释放

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Functional gradient scaffolds play an important role in osteochondral tissue engineering because they can meet the essential requirement for a gradual transition of both physical and chemical properties in osteochondral tissue regeneration. There is a requirement for 3D composite osteochondral regeneration scaffolds with multiscale structures that are capable of controlling release of multiple biomolecules. To this end, this article describes a 3D bioprinting platform integrated forming system designed to produce various drug-loaded scaffolds. A novel scaffold was fabricated by the self-developed 3D bioprinting platform combining extrusion deposition with multi-nozzle electrospinning. For temporally controlled release of gentamycin sulfate (GS) and desferoxamine (DFO), blend electrospun GS/polyvinyl alcohol (PVA) and coaxial electrospun core (PVA-DFO)/shell (polycaprolactone; PCL) fibers were deposited in the scaffold. After a 25-day time-lapse release study in vitro, results showed GS released faster than DFO during the early stages and sustained release of DFO for long periods. For spatially controlled release of DFO, the vertically gradient gelatin/sodium alginate (SA) scaffolds presented to enable the release amount of DFO in a gradient mode. The experiment and test results demonstrate the validity of the 3D bioprinting platform integrated forming system and the excellent properties of such scaffolds for performing multidrug spatiotemporal release. (C) 2015 Society of Plastics Engineers
机译:功能梯度支架在骨软骨组织工程中起着重要作用,因为它们可以满足骨软骨组织再生中物理和化学性质逐渐过渡的基本要求。需要具有多尺度结构的3D复合骨软骨再生支架,其能够控制多种生物分子的释放。为此,本文介绍了一个3D生物打印平台集成成型系统,该系统设计用于生产各种载有药物的支架。通过自行开发的3D生物打印平台结合挤出沉积和多喷嘴静电纺丝技术制造了新型支架。为了暂时控制硫酸庆大霉素(GS)和去铁胺(DFO)的释放,将静电纺丝GS /聚乙烯醇(PVA)和同轴静电纺丝芯(PVA-DFO)/壳(聚己内酯; PCL)纤维共混在支架中。经过25天的延时释放体外研究,结果显示GS在早期阶段的释放速度比DFO快,并且长期释放DFO。对于DFO的空间控制释放,提出了垂直梯度明胶/海藻酸钠(SA)支架,以使DFO能够以梯度模式释放。实验和测试结果证明了3D生物打印平台集成成型系统的有效性以及此类支架进行多药时空释放的出色性能。 (C)2015年塑料工程师学会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号